Doctor who said she would give Jews wrong medications loses medical license

Dr. Lara Kollab, who posted a series of anti-Semitic tweets while in college, has been fired by two separate hospitals. Image by facebook
(JTA) — The State Medical Board of Ohio permanently revoked the medical training certificate of a doctor who was fired from two residency programs after old anti-Semitic tweets surfaced — including one in which she threatened to give Jews the wrong medications.
Lara Kollab is permanently prohibited from practicing osteopathic medicine or surgery in Ohio, Cleveland.com reported. She surrendered her certificate prior to its revocation Aug. 12, according to the report, and cannot participate in another medical training program in the state.
Kollab wrote scores of anti-Semitic social media posts between 2011 to 2013 but deleted them after being accepted by the Touro College of Osteopathic Medicine in New York, which calls itself “the largest private university in the U.S. with Jewish roots.” In an apology after her tweets drew public attention, Kollab said she had written them because she had “difficulty constructively expressing my intense feelings about what I witnessed in my ancestral land,” following visits to Israel and the West Bank.
She was fired from a residency at the Cleveland Clinic after three months there in 2018, and was expelled from a second residency program at Kern Medical Center in Bakersfield, California, several months later.
The post Doctor who tweeted that she would give Jews the wrong medications loses Ohio medical certificate appeared first on Jewish Telegraphic Agency.
The Forward is free to read, but it isn’t free to produce

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
This is a great time to support independent Jewish journalism you rely on. Make a gift today!
— Rachel Fishman Feddersen, Publisher and CEO
Support our mission to tell the Jewish story fully and fairly.
Most Popular
- 1
Opinion The dangerous Nazi legend behind Trump’s ruthless grab for power
- 2
News Who is Alan Garber, the Jewish Harvard president who stood up to Trump over antisemitism?
- 3
News Student protesters being deported are not ‘martyrs and heroes,’ says former antisemitism envoy
- 4
Opinion What Jewish university presidents say: Trump is exploiting campus antisemitism, not fighting it
In Case You Missed It
-
Fast Forward A federal agency survey reportedly asks Barnard employees if they’re Jewish
-
Opinion A Palestinian leader just gave Trump an unprecedented opening to pursue peace
-
Fast Forward NIH bans grants for schools that boycott Israeli companies
-
Fast Forward An elite Jewish society at Yale fractures over its director’s embrace of Itamar Ben-Gvir
-
Shop the Forward Store
100% of profits support our journalism
Republish This Story
Please read before republishing
We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:
- Credit the Forward
- Retain our pixel
- Preserve our canonical link in Google search
- Add a noindex tag in Google search
See our full guidelines for more information, and this guide for detail about canonical URLs.
To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.